BIO Protocol recently raised a total of $30.2 million through private and public placements, demonstrating strong market interest in the project. The private placement phase consisted of two rounds of financing, with valuations of $35 million and $69 million respectively; the public placement phase completed three rounds of financing through the BIO Genesis auction, with valuations climbing from $85 million to $219 million. Currently, BIO is trading pre-market on Bybit and Bitget, with an FDV of approximately $3.2 billion. The investment returns for private and public investors reached 91.62 times and 37.73 times respectively, showcasing the project's strong growth potential.